Antibiotic Dosing in Pediatric Intensive Care

RecruitingOBSERVATIONAL
Enrollment

640

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2024

Study Completion Date

April 28, 2025

Conditions
PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactamVancomycinTeicoplaninMeropenemCiprofloxacinAmikacin
Interventions
PROCEDURE

blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care

PROCEDURE

blood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.

PROCEDURE

blood sampling in patients receiving vancomycin as part of routine clinical care.

PROCEDURE

blood sampling in patients receiving teicoplanin as part of routine clinical care.

PROCEDURE

blood sampling in patients receiving meropenem as part of routine clinical care.

PROCEDURE

blood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.

PROCEDURE

blood sampling in patients receiving amikacin as part of routine clinical care.

Trial Locations (1)

9000

RECRUITING

Ghent University Hospital, Hospital Pharmacy, Ghent

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

collaborator

Queen Fabiola Children's University Hospital, Brussels

UNKNOWN

lead

University Hospital, Ghent

OTHER

NCT02456974 - Antibiotic Dosing in Pediatric Intensive Care | Biotech Hunter | Biotech Hunter